107 related articles for article (PubMed ID: 31408676)
1. Delta/notch-like epidermal growth factor-related receptor promotes stemness to facilitate breast cancer progression.
Wang L; Wu Q; Li Z; Sun S; Yuan J; Li J; Zhang Y; Yu D; Wang C; Sun S
Cell Signal; 2019 Nov; 63():109389. PubMed ID: 31408676
[TBL] [Abstract][Full Text] [Related]
2. DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer.
Wang Z; Li Z; Wu Q; Li C; Li J; Zhang Y; Wang C; Sun S; Sun S
Cell Death Dis; 2020 Aug; 11(8):642. PubMed ID: 32811806
[TBL] [Abstract][Full Text] [Related]
3. Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis.
Liang Y; Luo H; Zhang H; Dong Y; Bao Y
Cancer Biother Radiopharm; 2018 Nov; 33(9):380-386. PubMed ID: 30235011
[TBL] [Abstract][Full Text] [Related]
4. Delta/notch-like epidermal growth factor-related receptor (DNER) orchestrates stemness and cancer progression in prostate cancer.
Wang L; Wu Q; Zhu S; Li Z; Yuan J; Yu D; Xu Z; Li J; Sun S; Wang C
Am J Transl Res; 2017; 9(11):5031-5039. PubMed ID: 29218101
[TBL] [Abstract][Full Text] [Related]
5. Delta/Notch-like Epidermal Growth Factor-Related Receptor (DNER), a Potential Prognostic Marker of Gastric Cancer Regulates Cell Survival and Cell Cycle Progression.
To HTN; Park JH; Kim JW; Kang D
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373228
[TBL] [Abstract][Full Text] [Related]
6. Quantum dot-based immunofluorescent imaging and quantitative detection of DNER and prognostic value in prostate cancer.
Wang L; Wu Q; Zhu S; Li Z; Yuan J; Liu L; Yu D; Xu Z; Li J; Sun S; Wang C
Cancer Biomark; 2018; 22(4):683-691. PubMed ID: 29843212
[TBL] [Abstract][Full Text] [Related]
7. hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.
Park S; Sung Y; Jeong J; Choi M; Lee J; Kwon W; Jang S; Park SJ; Kim HS; Lee MH; Kim DJ; Liu K; Kim SH; Dong Z; Ryoo ZY; Kim MO
Oncotarget; 2017 Jun; 8(23):37115-37127. PubMed ID: 28415749
[TBL] [Abstract][Full Text] [Related]
8. Upregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion.
Ye Y; Tang X; Sun Z; Chen S
Oncotarget; 2016 Apr; 7(14):17854-69. PubMed ID: 26895380
[TBL] [Abstract][Full Text] [Related]
9. DNER acts as a neuron-specific Notch ligand during Bergmann glial development.
Eiraku M; Tohgo A; Ono K; Kaneko M; Fujishima K; Hirano T; Kengaku M
Nat Neurosci; 2005 Jul; 8(7):873-80. PubMed ID: 15965470
[TBL] [Abstract][Full Text] [Related]
10. DNER as key molecule for cerebellar maturation.
Saito SY; Takeshima H
Cerebellum; 2006; 5(3):227-31. PubMed ID: 16997755
[TBL] [Abstract][Full Text] [Related]
11. Postoperative administration of ketorolac averts morphine-induced angiogenesis and metastasis in triple-negative breast cancer.
Liu Z; Cheng S; Fu G; Ji F; Wang C; Cao M
Life Sci; 2020 Jun; 251():117604. PubMed ID: 32243929
[TBL] [Abstract][Full Text] [Related]
12. Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer.
Choi JS; Kim KH; Oh E; Shin YK; Seo J; Kim SH; Park S; Choi YL
Pathology; 2017 Oct; 49(6):618-626. PubMed ID: 28818465
[TBL] [Abstract][Full Text] [Related]
13. Girdin maintains the stemness of glioblastoma stem cells.
Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
[TBL] [Abstract][Full Text] [Related]
14. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
[TBL] [Abstract][Full Text] [Related]
15. Akt-Girdin signaling in cancer-associated fibroblasts contributes to tumor progression.
Yamamura Y; Asai N; Enomoto A; Kato T; Mii S; Kondo Y; Ushida K; Niimi K; Tsunoda N; Nagino M; Ichihara S; Furukawa K; Maeda K; Murohara T; Takahashi M
Cancer Res; 2015 Mar; 75(5):813-23. PubMed ID: 25732845
[TBL] [Abstract][Full Text] [Related]
16. A systematic study of Girdin on cell proliferation, migration and angiogenesis in different breast cancer subtypes.
Wang H; Zhang J; Zhang M; Wei L; Chen H; Li Z
Mol Med Rep; 2017 Sep; 16(3):3351-3356. PubMed ID: 28713924
[TBL] [Abstract][Full Text] [Related]
17. Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells.
Shrivastava S; Kulkarni P; Thummuri D; Jeengar MK; Naidu VG; Alvala M; Redddy GB; Ramakrishna S
Apoptosis; 2014 Jul; 19(7):1148-64. PubMed ID: 24729100
[TBL] [Abstract][Full Text] [Related]
18. EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell Frequency.
Fu W; Lei C; Yu Y; Liu S; Li T; Lin F; Fan X; Shen Y; Ding M; Tang Y; Ye X; Yang Y; Hu S
Clin Cancer Res; 2019 May; 25(9):2835-2847. PubMed ID: 30670492
[TBL] [Abstract][Full Text] [Related]
19. The combination of NVP-BKM120 with trastuzumab or RAD001 synergistically inhibits the growth of breast cancer stem cells in vivo.
Yu F; Zhao J; Hu Y; Zhou Y; Guo R; Bai J; Zhang S; Zhang H; Zhang J
Oncol Rep; 2016 Jul; 36(1):356-64. PubMed ID: 27175939
[TBL] [Abstract][Full Text] [Related]
20. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
